Granules Pharmaceuticals

Granules Pharmaceuticals Inc. (GPI) is a 100% subsidiary of Granules India located in Chantilly, Virginia. GPI is a US FDA & DEA approved facility which spreads over 100,000 sft area, with established R&D & Manufacturing capabilities for low volume, oral solid dosage forms. GPI also distributes its products through a front end under the “GPI,” label. Our portfolio consists of low volume complex products to manufacture tablets, capsules, oral solutions and powder for oral solutions that are manufactured at our facility in Chantilly, medium to high volume, integrated products that are manufactured in our Finished dosage sites in India and products that are TAA compliant at the facility in Chantilly, VA.